Tilray, Inc.’s (NASDAQ: TLRY) Status as Global Pioneer in Cannabis Production, Distribution Reinforced by Earnings, Growth
First medical cannabis producer in North America to meet rigorous standards of GMP certification, supplying cannabis flower and extracts Canadian federally-licensed cannabis cultivator, processor and distributor Q2 2018 revenue increased to $9.7 million, up 95.2 percent over second quarter of 2017 Multinational distribution network makes Tilray medical cannabis available to patients in 11 countries on five continents Raised $163.6 million in a successful IPO in July 2018 and $55 million from leading institutional investors prior to IPO Agreements signed to supply medical cannabis via Canadian pharmacies and recreational cannabis to adult-use consumers in seven Canadian provinces and territories Received U.S.…